All stock lists
Ebang International Holdings In (NASDAQ:EBON)
US · Delayed Price · Currency is USD
Technology · Computer Hardware
1.73-0.16 (-8.47%)
Market cap
$10.9M
Insider Score
Health Score
Listed since
Jun 26, 2020
Website
Insider Score
––Not scored
EBON Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From EBON’s reported statements · Q2 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $14.2M
- Net income
- -$31.0M
- Net margin
- -218.2%
Leverage20 / 20
Little or no net debt.
- Total debt
- $1.2M
- Cash
- $179.8M
- Debt / equity
- 0.01
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $207.0M
- Current liabilities
- $7.2M
- Current ratio
- 28.65
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$17.6M
- Free cash flow
- -$22.6M
- FCF margin
- -158.6%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 6.3M
- Share growth (1y)
- 0.0%
- Cash runway
- 123 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
EBON Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Dec 31, 2025 | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 |
| Revenue | 3.92 M | 2.95 M | 3.58 M | 3.75 M | 2.11 M | 768.84 K |
| Revenue Growth (YoY) | 85.63 % | 284.32 % | -12.34 % | -48.34 % | -91.56 % | -97.68 % |
| Cost of Revenue | 3.20 M | 1.91 M | 4.23 M | 2.65 M | 2.03 M | 18.47 M |
| Gross Profit | 727.41 K | 1.04 M | -648.54 K | 1.11 M | 81.84 K | -17.70 M |
| SG&A Expense | 10.95 M | 13.06 M | 10.21 M | 19.06 M | 12.50 M | 17.30 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 425.95 K | 0.00 | 7.40 M |
| Operating Expenses | 10.95 M | 13.06 M | 10.21 M | 19.06 M | 12.50 M | 23.31 M |
| Operating Income | -10.22 M | -12.02 M | -10.86 M | -17.96 M | -12.42 M | -41.00 M |
| Pretax Income | -5.54 M | -9.96 M | -4.53 M | -14.25 M | -6.66 M | -30.68 M |
| Tax Provision | 0.00 | -290.76 K | -30.22 K | -24.62 K | -17.93 K | -1.03 M |
| Net Income | -2.90 M | -9.58 M | -4.51 M | -14.02 M | -6.23 M | -28.95 M |
| EPS (Basic) | -0.46 | -1.53 | -0.72 | -2.23 | -0.99 | -4.61 |
| EPS (Diluted) | -0.46 | -1.53 | -0.72 | -2.23 | -0.99 | -4.61 |
| Shares Outstanding | 6.28 M | 6.28 M | 6.27 M | 6.28 M | 6.28 M | 6.28 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.